NCT02999191View on ClinicalTrials.gov

Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

March 15, 2017

Study Completion Date

April 10, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

BI 1467335 (Treatment A)

DRUG

BI 1467335 (Treatment B)

DRUG

BI 1467335 (Treatment C)

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY